About this journal

Cancer Management and Research is part of our Elevate Series. This means that you will receive a concierge-level publishing experience, including dedicated support from our expert in-house Editorial team.

Cancer Management and Research is an international, peer reviewed, open access journal focusing on cancer research and the optimal use of preventative and integrated treatment interventions to achieve improved outcomes, enhanced survival, and quality of life for cancer patients.

Cancer Management and Research will no longer consider meta-analyses for publication.

Specific topics covered in the journal include:

• Epidemiology, detection and screening
• Cellular research and biomarkers
• Identification of biotargets and agents with novel mechanisms of action
• Optimal clinical use of existing anticancer agents, including combination therapies
• Radiation and surgery
• Palliative care
• Patient adherence, quality of life, satisfaction

The journal welcomes submitted papers covering original research, basic science, clinical & epidemiological studies, reviews & evaluations, guidelines, expert opinion and commentary, and case series that shed novel insights on a disease or disease subtype.

When considering submission of a paper utilizing publicly-available data (e.g. SEER/GWAS/TCGA/GEO etc.), authors should ensure that such studies add significantly to the body of knowledge about a specific disease or relevant phenotype and that they are validated using the authors’ own data through replication in an independent sample set and functional follow-up. Bioinformatics studies should also conform to these criteria.

The journal does not consider case reports except in circumstances where they make a valuable contribution to the literature. Cell line studies must demonstrate thorough and rigorous protocols, and biomarker association studies must be supported by in vivo validations. Tissue microarray analyses and single nucleotide polymorphism (SNP) studies will not be considered.

Associate Editors-in-Chief:

Dr Antonella D'Anneo, Department of Biological, Chemical and Pharmaceutical Sciences and Technologies, University of Palermo, Palermo, Italy

Professor Bilikere Dwarakanath, Indian Academy Degree College-Autonomous, Bengaluru, India

Dr Ahmet Emre Eşkazan, Department of Internal Medicine, Division of Hematology, Istanbul University-Cerrahpaşa, Istanbul, Turkey

Professor Kattesh Katti, Institute of Green Nanotechnology and Cancer Nanotechnology, Department of Radiology, University of Missouri, Columbia, MO, USA

Dr Chien-Feng Li, National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan

Professor Harikrishna Nakshatri, Professor of Surgery, Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, IN, USA

Professor Seema Singh, Department of Pathology, Mitchell Cancer Institute, University of South Alabama, Mobile, AL, USA

Dr Sanjeev K. Srivastava, Department of Pathology, Mitchell Cancer Institute, University of South Alabama, Mobile, AL, USA

Professor Lu-Zhe Sun, Department of Cell Systems & Anatomy, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA

Professor Yong Teng, Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, USA

Editorial Board:

Dr Oronzo Brunetti, Medical Assistance – Medical Oncology Unit, National Cancer Institute, Italy.

Dr Damiano Chiari, MD, Department of General Surgery, Humanitas Mater Domini Clinical Institute, Humanitas University, Italy

Professor Brendon Coventry, Associate Professor of Surgery, Discipline of Surgery, University of Adelaide, Royal Adelaide Hospital, South Australia, Australia 5000

Prof. Dr. Alfio Ferlito, Professor of Otorhinolaryngology-Head and Neck Surgery, Coordinator of the International Head Neck Scientific Group (www.IHNSG.com)

Dr Gary L Johanning, Chief Scientific Officer, SunnyBay Biotech, USA.

Dr Cheryl L. Jorcyk, Director, Clinical & Translational Research; Professor, Biological Sciences, Boise State University, Boise, ID, USA. Dr. Jorcyk's lab investigates the role of inflammatory cytokines in breast cancer invasion and metastasis.

Professor Evan Keller, Professor, Department of Urology and Pathology, University of Michigan, Ann Arbor, MI, USA

Dr Silvana Morello, PhD, Assistant Professor of Clinic Pharmacology and Immunopharmacology, Department of Pharmacy, University of Salerno, Salerno, Italy.

Professor Birija Sankar Patro, Head, Bio-Organic Division, Mod. Lab, Bhabha Atomic Research Centre, Mumbai, India.

Dr Santosh Kumar Singh, Ph.D., Department of Microbiology, Biochemistry & Immunology, Morehouse School of Medicine, Atlanta, GA, USA

Professor Johnson Stanslas, Professor, Pharmacotherapeutics Unit, Department of Medicine, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Malaysia

Professor Friedrich Stölzel, Professor, Department of Internal Medicine I, University Hospital Dresden, Germany

Prof. Dr. Jing Zhang, Professor in Department of Pathology, State Key Laboratory of Tumor Biology, Xijing Hospital, Fourth Military Medical University, Xi’an, Shaanxi, China.

Dr Guo Zhao, Clinical Trial Center, National Cancer Center/National Clinical Research Center for Cancer/Cancer Ho, Peking Union Medical College, China.